Simulations Plus Total Liabilities 2010-2024 | SLP
Simulations Plus total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Simulations Plus Annual Total Liabilities
(Millions of US $) |
| 2024 |
$14 |
| 2023 |
$16 |
| 2022 |
$10 |
| 2021 |
$14 |
| 2020 |
$12 |
| 2019 |
$8 |
| 2018 |
$11 |
| 2017 |
$13 |
| 2016 |
$5 |
| 2015 |
$8 |
| 2014 |
$6 |
| 2013 |
$2 |
| 2012 |
$2 |
| 2011 |
$2 |
| 2010 |
$2 |
| 2009 |
$2 |
Simulations Plus Quarterly Total Liabilities
(Millions of US $) |
| 2024-08-31 |
$14 |
| 2024-05-31 |
$12 |
| 2024-02-29 |
$17 |
| 2023-11-30 |
$13 |
| 2023-08-31 |
$16 |
| 2023-05-31 |
$10 |
| 2023-02-28 |
$9 |
| 2022-11-30 |
$10 |
| 2022-08-31 |
$10 |
| 2022-05-31 |
$9 |
| 2022-02-28 |
$12 |
| 2021-11-30 |
$13 |
| 2021-08-31 |
$14 |
| 2021-05-31 |
$14 |
| 2021-02-28 |
$14 |
| 2020-11-30 |
$12 |
| 2020-08-31 |
$12 |
| 2020-05-31 |
$15 |
| 2020-02-29 |
$8 |
| 2019-11-30 |
$9 |
| 2019-08-31 |
$8 |
| 2019-05-31 |
$10 |
| 2019-02-28 |
$10 |
| 2018-11-30 |
$10 |
| 2018-08-31 |
$11 |
| 2018-05-31 |
$12 |
| 2018-02-28 |
$12 |
| 2017-11-30 |
$13 |
| 2017-08-31 |
$13 |
| 2017-05-31 |
$4 |
| 2017-02-28 |
$5 |
| 2016-11-30 |
$5 |
| 2016-08-31 |
$5 |
| 2016-05-31 |
$7 |
| 2016-02-29 |
$8 |
| 2015-11-30 |
$8 |
| 2015-08-31 |
$8 |
| 2015-05-31 |
$8 |
| 2015-02-28 |
$8 |
| 2014-11-30 |
$9 |
| 2014-08-31 |
$6 |
| 2014-05-31 |
$6 |
| 2014-02-28 |
$2 |
| 2013-11-30 |
$2 |
| 2013-08-31 |
$2 |
| 2013-05-31 |
$2 |
| 2013-02-28 |
$2 |
| 2012-11-30 |
$2 |
| 2012-08-31 |
$2 |
| 2012-05-31 |
$3 |
| 2012-02-29 |
$3 |
| 2011-11-30 |
$2 |
| 2011-08-31 |
$2 |
| 2011-05-31 |
$3 |
| 2011-02-28 |
$2 |
| 2010-11-30 |
$2 |
| 2010-08-31 |
$2 |
| 2010-05-31 |
$2 |
| 2010-02-28 |
$2 |
| 2009-11-30 |
$2 |
| 2009-08-31 |
$2 |
| 2009-05-31 |
$2 |
| 2009-02-28 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.580B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
